Study Design
POLAND
The Beta3-LVH is a prospective, parallel, placebo-controlled, triple-blind phase 2b randomized clinical trial that was performed in 10 academic hospitals in Germany (3 centers), Poland, France, Belgium, Italy, Portugal, Greece, and the UK. Complete details on the trial protocol were reported previously